Macquarie Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,497
| Closed | -$3.85K | – | 1656 |
|
|
2024
Q2 | $3.85K | Buy |
+3,497
| New | +$3.85K | ﹤0.01% | 1744 |
|
|
2022
Q4 | – | Sell |
-1,568
| Closed | -$25K | – | 1744 |
|
|
2022
Q3 | $25K | Hold |
1,568
| – | – | ﹤0.01% | 2129 |
|
|
2022
Q2 | $22K | Hold |
1,568
| – | – | ﹤0.01% | 2271 |
|
|
2022
Q1 | $27 | Hold |
1,568
| – | – | ﹤0.01% | 2311 |
|
|
2021
Q4 | $23K | Hold |
1,568
| – | – | ﹤0.01% | 2360 |
|
|
2021
Q3 | $28K | Buy |
+1,568
| New | +$28K | ﹤0.01% | 2374 |
|